Skip to search formSkip to main contentSkip to account menu

bisaramil

Known as: syn-3-ethyl-7-methyl-3,7-diazabicyclo(3.3.1)non-9-yl p- chlorobenzoate, yutac 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Bridged Bicyclo Compounds, HeterocyclicChlorobenzenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801.
1996
1996
Effects of quantization on the electrical characteristics of deep submicron p- and n-MOSFETs
A first-principles approach to inversion layer quantization for arbitrarily complex band structures has been developed that has… 
1995
1995
Estimation of impurity profiles of drugs and related materials. Part 14: the role of HPLC/diode-array UV spectroscopy in the identification of minor components (impurities, degradation products…
1995
1995
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Antiarrhythmic effects of bisaramil were examined by using new in vivo triggered arrhythmia models, and they were compared with… 
1992
1992
Monoclonal antibodies against soman: characterization of soman stereoisomers.
1976
1976
Mechanisms of phytohaemagglutinin-P-, concanavalin-A- and kaolin-induced oedemas in the rat.
1973
1973
Neutral hetero- -galactosidase from rabbit small intestine.
1972
1972
-galactosidase activity of human skin fibroblasts.
1970
1970
Erythrocyte membrane interactions with menadione and the mechanism of menadione-induced hemolysis.
Review
1964
Review
1964
SOME REMARKS ON THE PHARMACOLOGY OP RADIOPROTECTANT AGENTS
A striking parallelisra between pharraacological activity and radiation protection was clearly demonstrated for serotonin… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)